Analysis of preventive therapy in patients after recanalization of the femoral artery
- Autores: Stolyarova V.V.1, Shokina S.V.1, Skopina Y.A.1, Kunyaeva T.A.1, Suraeva E.V.1, Shabanov I.G.1, Zorkin M.V.1
-
Afiliações:
- N.P. Ogarev National Research Mordovia State University
- Edição: Volume 9, Nº 8 (2023)
- Páginas: 20-27
- Seção: ORIGINAL STUDIES
- URL: https://journals.eco-vector.com/2412-4036/article/view/624614
- DOI: https://doi.org/10.18565/therapy.2023.8.20–27
- ID: 624614
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
In modern clinical practice, the analysis of preventive therapy after recanalization of the femoral artery in patients with lower extremity arterial diseases (LEAD) caused by atherosclerotic lesions seems to be a pressing issue.
Objective: dynamic assessment of results after recanalization of the femoral artery and preventive therapy in patients with LEAD.
Material and methods. Long-term results of recanalization, risk factors, and adherence to an individual approach were studied in 30 patients after 3, 6 and 9 months.
Results. Most patients with LEAD have comorbid pathology and a combination of several risk factors (smoking, arterial hypertension, excess body weight, increased LDL levels). In 80% of patients with LEAD over 9 months of observation, there was no deterioration in the clinical picture achieved after revascularization. There was low adherence to preventive treatment, which decreased with increasing time after discharge from hospital. An important reason for non-compliance with recommendations is low patient awareness of the need for preventive therapy and the significance of risk factors for the prognosis of the disease.
Conclusion. There is significant unrealized potential in the treatment of patients with LEAD to improve outcomes after revascularization. There is a need to more strictly monitor the implementation of recommendations for secondary prevention of the disease and to increase patient awareness of the importance of smoking, excess body weight, achieving the target level of blood pressure and lipid spectrum indicators on the course and prognosis of the disease.
Texto integral
Sobre autores
Vera Stolyarova
N.P. Ogarev National Research Mordovia State University
Autor responsável pela correspondência
Email: vera_s00@mail.ru
ORCID ID: 0000-0002-6164-4737
MD, professor, head of the Department of outpatient therapy, N.P. Ogarev National Research Mordovia State University
Rússia, SaranskSvetlana Shokina
N.P. Ogarev National Research Mordovia State University
Email: sveti-kh@mail.ru
ORCID ID: 0000-0001-8650-1778
PhD in Medical Sciences, associate professor of the Department of outpatient therapy, N.P. Ogarev National Research Mordovia State University
Rússia, SaranskYulia Skopina
N.P. Ogarev National Research Mordovia State University
Email: skopina@bk.ru
ORCID ID: 0000-0001-7598-5690
PhD in Medical Sciences, associate professor of the Department of outpatient therapy, N.P. Ogarev National Research Mordovia State University
Rússia, SaranskTatyana Kunyaeva
N.P. Ogarev National Research Mordovia State University
Email: kunya_eva@mail.ru
ORCID ID: 0000-0003-4245-4265
PhD in Medical Sciences, associate professor of the Department of outpatient therapy, N.P. Ogarev National Research Mordovia State University
Rússia, SaranskElizaveta Suraeva
N.P. Ogarev National Research Mordovia State University
Email: liza.suraeva@mail.ru
student of N.P. Ogarev National Research Mordovia State University
Rússia, SaranskIlya Shabanov
N.P. Ogarev National Research Mordovia State University
Email: shhabanov@mail.ru
student of N.P. Ogarev National Research Mordovia State University
Rússia, SaranskMikhail Zorkin
N.P. Ogarev National Research Mordovia State University
Email: saerdan@mail.ru
ORCID ID: 0000-0002-1862-6613
PhD in Medical Sciences, associate professor of the Department of outpatient therapy, N.P. Ogarev National Research Mordovia State University
Rússia, SaranskBibliografia
- Кухарчук В.В., Ежов М.В., Сергиенко И.В. с соавт. Клинические рекомендации евразийской ассоциации кардиологов (ЕАК)/ национального общества по изучению атеросклероза (НОА, Россия) по диагностике и коррекции нарушений липидного обмена с целью профилактики и лечения атеросклероза (2020). Евразийский кардиологический журнал. 2020; (2): 6–29. [Kukharchuk V.V., Ezhov M.V., Sergienko I.V. et al. Eurasian Association of Cardiology (EAC)/ Russian national atherosclerosis society (RNAS, Russia) guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2020). Evraziyskiy kardiologicheskiy zhurnal = Eurasian Heart Journal. 2020; (2): 6–29 (In Russ.)]. https://dx.doi.org/10.38109/2225-1685-2020-2-6-29. EDN: YPOQHT.
- Федеральная служба государственной статистики (Росстат). Российский статистический ежегодник. М. 2022; 691 с. Доступ: https://rosstat.gov.ru/storage/mediabank/Ejegodnik_2022.pdf (дата обращения – 01.10.2023). [Federal State Statistics Service (Russia). Russian Statistical Yearbook. Moscow. 2022; 691 pp. URL: https://rosstat.gov.ru/storage/mediabank/Ejegodnik_2022.pdf (date of access – 01.10.2023) (In Russ.)].
- Национальные рекомендации по диагностике и лечению заболеваний артерий нижних конечностей. Ассоциация сердечно-сосудистых хирургов России, Российское общество ангиологов и сосудистых хирургов, Российское общество хирургов, Российское кардиологическое общество, Российская ассоциация эндокринологов. 2019. Доступ: https://www.angiolsurgery.org/library/recommendations/2019/recommendations_LLA_2019.pdf (дата обращения – 01.10.2023). [National guidelines for the diagnosis and treatment of diseases of the arteries of the lower extremities. Association of Cardiovascular Surgeons of Russia, Russian Society of Angiologists and Vascular Surgeons, Russian Society of Surgeons, Russian Society of Cardiology, Russian Association of Endocrinologists. 2019. URL: https://www.angiolsurgery.org/library/recommendations/2019/recommendations_LLA_2019.pdf (date of access – 01.10.2023) (In Russ.)].
- Лукашова А.В. Применение медицинского озона и гравитационной терапии в комплексном лечении гериатрических пациентов с облитерирующим атеросклерозом артерий нижних конечностей: специальность 14.01.30 «Геронтология и гериатрия»: диссертация на соискание ученой степени кандидата медицинских наук. 2018; 176 с. Доступ: https://www.dissercat.com/content/primenenie-meditsinskogo-ozona-i-gravitatsionnoi-terapii-v-kompleksnom-lechenii-geriatriches (дата обращения – 01.10.2023). [Lukashova A.V. The use of medical ozone and gravitational therapy in the complex treatment of geriatric patients with obliterating atherosclerosis of the arteries of the lower extremities: Specialty 01/14/30 «Gerontology and Geriatrics»: dissertation for the degree of PhD in Medical Sciences. 2018: 176 p. URL: https://www.dissercat.com/content/primenenie-meditsinskogo-ozona-i-gravitatsionnoi-terapii-v-kompleksnom-lechenii-geriatriches (date of access – 01.10.2023) (In Russ.)].
- Гавриленко А.В., Ван Сяочэнь, Аль-Юсеф Н.Н. Современные возможности в прогнозировании результатов хирургического лечения больных с хронической ишемией нижних конечностей. Кардиология и сердечно-сосудистая хирургия. 2017; 10(5): 52–57. [Gavrilenko A.V., Wang Xiaochen, Al-Yousef N.N. Modern possibilities to predict surgical outcomes in patients with chronic lower limb ischemia. Kardiologiya i serdechno-sosudistaya khirurgiya = Cardiology and Cardiovascular Surgery. 2017; 10(5): 52–57 (In Russ.)]. https://dx.doi.org/10.17116/kardio201710552-57. EDN: ZKAAFJ.
- Antoniou G.A., Fisher R.K., Georgiadis G.S. et al. Statin therapy in lower limb peripheral arterial disease: Systematic review and meta-analysis. Vascul. Pharmacol. 2014; 63(2): 79–87. https://dx.doi.org/10.1016/j.vph.2014.09.001.
- Сергиенко И.В., Аншелес А.А., Кухарчук В.В. Дислипидемии, атеросклероз и ишемическая болезнь сердца. Генетика, патогенез, фенотипы, диагностика, терапия, коморбидность. Изд. 4-е, перераб. и доп. М.: Патисс. 2020; 297 с. [Sergienko I.V., Ansheles A.A., Kukharchuk V.V. Dyslipidemia, atherosclerosis and coronary heart disease. Genetics, pathogenesis, phenotypes, diagnosis, therapy, comorbidity. 4th edition, revised and expanded. Moscow: Patiss. 2020; 297 pp. (In Russ.)]. ISBN: 978-5-90363-366-1.
- Кобалава Ж.Д., Конради А.О., Недогода С.В. с соавт. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 25(3): 149–218. [Kobalava Zh.D., Konradi A.O., Nedogoda S.V. et al. Arterial hypertension in adults. Clinical guidelines 2020. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 25(3): 149–218 (In Russ.)]. https://dx.doi.org/10.15829/1560-4071-2020-3-3786. EDN: TCRBRB.
- Покровский А.В., Харазов А.Ф., Сапелкин С.В. Консервативное лечение пациентов с перемежающейся хромотой. Ангиология и сосудистая хирургия. 2014; 20(1): 173–180. [Pokrovsky A.V., Khazarov A.F., Sapelkin S.V. Conservative treatment of patients with intermittent claudication. Angiologia i sosudistaya khirurgia = Angiology and Vascular Surgery. 2014; 20(1): 173–180 (In Russ.)]. EDN: RXMBRJ.
- Society for Vascular Surgery Lower Extremity Guidelines Writing Group; Conte M.S., Pomposelli F.B., Clair D.G. et al.; Society for Vascular Surgery. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J. Vasc. Surg. 2015; 61(3 Suppl): 2S–41S. https://dx.doi.org/10.1016/j.jvs.2014.12.009.
- Лукина Ю.В., Кутишенко Н.П., Марцевич С.Ю. с соавт. Методические рекомендации: «Приверженность к лекарственной терапии у больных хроническими неинфекционными заболеваниями. Решение проблемы в ряде клинических ситуаций». Профилактическая медицина. 2020; 23(3–2): 42–60. [Lukina Yu.V., Kutishenko N.P., Martsevich S.Yu. et al. Methodological recommendations: " Adherence to drug therapy in patients with chronic non-communicable diseases. Addressing the problem in a number of clinical situations". Profilakticheskaya meditsina = Preventive Medicine. 2020; 23(3–2): 42–60 (In Russ.)]. https://dx.doi.org/10.17116/profmed20202303242. EDN: KEFJWR.
- Койчуев А.А. Приверженность в лечении: методики оценки, технологии коррекции недостаточной приверженности терапии. Медицинский вестник Северного Кавказа. 2013; 8(3): 65–69. [Koychuev A.A. Adherence to treatment: techniques, technologies correcting inadequate adherence to therapy. Meditsinskiy vestnik Severnogo Kavkaza = Medical News of North Caucasus. 2013; 8(3): 65–69 (In Russ.)]. EDN: REMDET.
- Государственный реестр лекарственных средств Минздрава России. Доступ: https://grls.rosminzdrav.ru/ (дата обращения – 01.09.2023). [State Register of Medicines of the Ministry of Healthcare of Russia. URL: https://grls.rosminzdrav.ru/ (date of access – 01.09.2023) (In Russ.)].
- Радченко Е.В., Суховская О.А., Галанкин Т.Л. с соавт. Сетевой метаанализ: сравнение эффективности и безопасности частичных агонистов никотиновых ацетилхолиновых рецепторов варениклина и цитизина для лечения никотиновой зависимости. Обзоры по клинической фармакологии и лекарственной терапии. 2018; 16(4): 19–32. [Radchenko E.V., Sykhovskaya O.A., Galankin T.L. et al. Network meta-analysis: A comparison of effectiveness and safety of partial agonists of nicotinic acetylcholine receptors varenicline and cytisine for smoking cessation. Obzory po klinicheskoy farmakologii i lekarstvennoy terapii = Reviews on Clinical Pharmacology and Drug Therapy. 2018; 16(4): 19–32 (In Russ.)]. https://dx.doi.org/10.17816/RCF16419-32. EDN: YWXLKH.
Arquivos suplementares
